Drugs / AGN-241622
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04403763 | Jul 2020 → Dec 2022 | presbyopia | AbbVie | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGN-241622 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04403763 ↗ |
| Route | Topical | “Topical eye drop” NCT04403763 ↗ |